UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics

Cold Spring Harbor Symposia on Quantitative Biology, 2007, Vol.72 (1), p.465-475

2007

Volltextzugriff (PDF)

Low immunogenicity of seasonal trivalent influenza vaccine among patients receiving docetaxel for a solid tumour: results of a prospective pilot study

British journal of cancer, 2011-05, Vol.104 (11), p.1670-1674

2011

Volltextzugriff (PDF)

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

The Lancet (British edition), 2019-06, Vol.393 (10191), p.2591-2598

2019

Volltextzugriff (PDF)

Concentrations of Galectin-3 in the Sera of Normal Controls and Cancer Patients

Clinical cancer research, 2000-04, Vol.6 (4), p.1389-1393

2000

Volltextzugriff (PDF)

Dynamic circadian system patients under chimiotherapy

Pathologie biologie (Paris), 2007-04, Vol.55 (3-4), p.171-175

2007

Volltextzugriff (PDF)

Immunohistochemical and serological 90K/Mac-2BP detection in hepatocellular carcinoma patients: different behaviour of two monoclonal antibodies

Medicinal chemistry (Shp-sariqah, United Arab Emirates), 2005-03, Vol.1 (2), p.185-189

2005

Volltextzugriff (PDF)

Relations of circadian clocks genes with endocrine, proliferation, differentiation, and P53 mutation status in human locally invasive primary breast cancer

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.10589-10589

2010

Volltextzugriff (PDF)

Abstract P2-09-26: Circadian Clock Genes in Primary Breast Cancer: Strong Predictors of Pathologic Response on Neoadjuvant Chemotherapy

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P2-P2-09-26

2010

Volltextzugriff (PDF)

Heterogeneous Amplification of HER2 Is a Rare but Clinically Significant Event in Invasive Ductal Carcinoma

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.6034-6034

2009

Volltextzugriff (PDF)

LIVER CIRCADIAN CLOCK, A PHARMACOLOGIC TARGET OF CYCLIN-DEPENDENT KINASE INHIBITOR SELICICLIB

Chronobiology international, 2009-08, Vol.26 (6), p.1169-1188

2009

Volltextzugriff (PDF)

Dynamique du système circadien de patients sous chimiothérapie

Pathologie biologie (Paris), 2007-04, Vol.55 (3), p.171-175

2007

Volltextzugriff (PDF)

Design and Production of Innovative Turbomachinery Components via Topology Optimization and Additive Manufacturing

International journal of rotating machinery, 2019, Vol.2019, p.1-12

2019

Volltextzugriff (PDF)

Clinical/molecular features and prognostic significance of RAS mutant-low versus RAS mutant-high in patients with metastatic colorectal cancer

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.187-187

2024

Volltextzugriff (PDF)

The circadian rest‐activity rhythm, a potential safety pharmacology endpoint of cancer chemotherapy

International journal of cancer, 2014-06, Vol.134 (11), p.2717-2725

2014

Volltextzugriff (PDF)

Static and Modal Topology Optimization of Turbomachinery Components

Journal of engineering for gas turbines and power, 2016-11, Vol.138 (11)

2016

Volltextzugriff (PDF)

Impact on treatment adherence, side effects control, patients QoL, and rehospitalization rate through new management of oral chemotherapy

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e18533-e18533

2018

Volltextzugriff (PDF)

Synthetic lactulose amines: novel class of anticancer agents that induce tumor-cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis

Glycobiology (Oxford), 2006-03, Vol.16 (3), p.210-220

2006

Volltextzugriff (PDF)

The Developmentally Regulated Osteoblast Phosphodiesterase GDE3 Is Glycerophosphoinositol-specific and Modulates Cell Growth

The Journal of biological chemistry, 2009-09, Vol.284 (37), p.24848-24856

2009

Volltextzugriff (PDF)

Improved tumor control through circadian clock induction by seliciclib, a cyclin-dependent kinase inhibitor

Cancer research (Chicago, Ill.), 2006-11, Vol.66 (22), p.10720-10728

2006

Volltextzugriff (PDF)

90K (Mac-2 BP) and galectins in tumor progression and metastasis

Glycoconjugate journal, 2002, Vol.19 (7-9), p.551-556

2002

Volltextzugriff (PDF)

Identification of a new polyphosphoinositide in plants, phosphatidylinositol 5-monophosphate (PtdIns5P), and its accumulation upon osmotic stress

Biochemical journal, 2001-12, Vol.360 (Pt 2), p.491-498

2001

Volltextzugriff (PDF)

Synthetic Inhibitors of Galectin-1 and -3 Selectively Modulate Homotypic Cell Aggregation and Tumor Cell Apoptosis

Anticancer research, 2009-01, Vol.29 (1), p.403-410

2009

Volltextzugriff (PDF)

Phospholipase A2IVα Regulates Phagocytosis Independent of Its Enzymatic Activity

The Journal of biological chemistry, 2012-05, Vol.287 (20), p.16849-16859

2012

Volltextzugriff (PDF)

Biological activities and metabolism of the lysophosphoinositides and glycerophosphoinositols

Biochimica et biophysica acta, 2002-05, Vol.1582 (1), p.52-69

2002

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(53)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics

Low immunogenicity of seasonal trivalent influenza vaccine among patients receiving docetaxel for a solid tumour: results of a prospective pilot study

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial

Concentrations of Galectin-3 in the Sera of Normal Controls and Cancer Patients

Dynamic circadian system patients under chimiotherapy

Immunohistochemical and serological 90K/Mac-2BP detection in hepatocellular carcinoma patients: different behaviour of two monoclonal antibodies

Relations of circadian clocks genes with endocrine, proliferation, differentiation, and P53 mutation status in human locally invasive primary breast cancer

Abstract P2-09-26: Circadian Clock Genes in Primary Breast Cancer: Strong Predictors of Pathologic Response on Neoadjuvant Chemotherapy

Heterogeneous Amplification of HER2 Is a Rare but Clinically Significant Event in Invasive Ductal Carcinoma

LIVER CIRCADIAN CLOCK, A PHARMACOLOGIC TARGET OF CYCLIN-DEPENDENT KINASE INHIBITOR SELICICLIB

Dynamique du système circadien de patients sous chimiothérapie

Design and Production of Innovative Turbomachinery Components via Topology Optimization and Additive Manufacturing

Clinical/molecular features and prognostic significance of RAS mutant-low versus RAS mutant-high in patients with metastatic colorectal cancer

The circadian rest‐activity rhythm, a potential safety pharmacology endpoint of cancer chemotherapy

Static and Modal Topology Optimization of Turbomachinery Components

Impact on treatment adherence, side effects control, patients QoL, and rehospitalization rate through new management of oral chemotherapy

Synthetic lactulose amines: novel class of anticancer agents that induce tumor-cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis

The Developmentally Regulated Osteoblast Phosphodiesterase GDE3 Is Glycerophosphoinositol-specific and Modulates Cell Growth

Improved tumor control through circadian clock induction by seliciclib, a cyclin-dependent kinase inhibitor

90K (Mac-2 BP) and galectins in tumor progression and metastasis

Identification of a new polyphosphoinositide in plants, phosphatidylinositol 5-monophosphate (PtdIns5P), and its accumulation upon osmotic stress

Synthetic Inhibitors of Galectin-1 and -3 Selectively Modulate Homotypic Cell Aggregation and Tumor Cell Apoptosis

Phospholipase A2IVα Regulates Phagocytosis Independent of Its Enzymatic Activity

Biological activities and metabolism of the lysophosphoinositides and glycerophosphoinositols

Suchergebnisse filtern